NCT06436690

Brief Summary

Interventions that are low-cost, do not add substantially to the physician workload, are consistent with good physician practices and WHO guidelines, and serve as a reminder on the risks of overprescribing antibiotics are critically needed. The overall goal of the proposed project is to test the effect of two behavioral interventions targeted to junior physicians-specifically, requiring them to specify the diagnosis in the prescription note and providing feedback-on their antibiotics prescription rate; examine the intervention's effects across gender and caste; and draw lessons for scaling up the intervention.

Trial Health

58
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2025

Geographic Reach
2 countries

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 24, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 31, 2024

Completed
11 months until next milestone

Study Start

First participant enrolled

April 15, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 28, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2026

Completed
Last Updated

December 5, 2025

Status Verified

November 1, 2025

Enrollment Period

8 months

First QC Date

May 24, 2024

Last Update Submit

November 30, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Antibiotics prescription rate

    The number of patient visits in which antibiotics are prescribed by the total number of visits

    1-3 months before the intervention and 3-5 months after the intervention, depending on the timing of the intervention which varies by hospital.

Secondary Outcomes (2)

  • Differences in prescription rates by patient's gender

    1-3 months before the intervention and 3-5 months after the intervention, depending on the timing of the intervention which varies by hospital.

  • Differences in prescription rates by patient's ethnicity (advantaged versus disadvantaged)

    1-3 months before the intervention and 3-5 months after the intervention, depending on the timing of the intervention which varies by hospital.

Study Arms (3)

Control

NO INTERVENTION

During this phase, physicians do not receive any intervention.

Diagnosis Mandate

EXPERIMENTAL

In this phase, physicians receive a refresher training on AMR and a letter requiring the physicians to specify the diagnosis in their prescription note.

Behavioral: Diagnosis Mandate

Feedback

EXPERIMENTAL

In this phase, physicians receive a customized feedback letter on their prescription behavior, including antibiotics prescription rate.

Behavioral: Individualized Feedback

Interventions

The intervention consists of: a) a Refresher Training on AMR, and (b) a Diagnosis Mandate.

Diagnosis Mandate

Physicians receive a customized feedback on their prescription behavior, including antibiotics prescription rate.

Feedback

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 18+
  • working at an outpatient clinic in one of the participating hospitals.

You may not qualify if:

  • \<18 years of age
  • working at more than one of the participating hospitals
  • For patients:
  • age 18+
  • sought care at one of the outpatient clinics in the participating hospitals.
  • \<18 years of age
  • one of the vulnerable populations (pregnant women, cognitively impaired adults)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Pennsylvania State University

University Park, Pennsylvania, 16801, United States

Location

Institute for Social and Environmental Research - Nepal

Bharatpur, Bagmati, 44200, Nepal

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
CROSSOVER
Model Details: This is a stepped-wedge randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 24, 2024

First Posted

May 31, 2024

Study Start

April 15, 2025

Primary Completion

November 28, 2025

Study Completion

April 30, 2026

Last Updated

December 5, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

There are potential risks about confidentiality, as the number of physicians is small.

Locations